These findings offer a refined perspective on the molecular mechanisms underpinning MLL-associated leukemia, highlighting the potential of ZEB1 and ZEB2 as EMT factors to be critical components within this oncogenic network in AML. This evidence concerns the gene KMT2A and acute myeloid leukemia.